These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3809778)

  • 1. [Industrial drug-surveillance. Spontaneous notification: data collection, survey].
    Trunet P
    Rev Med Interne; 1986 Nov; Spec No():35-9. PubMed ID: 3809778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Industrial drug-surveillance].
    Juillet Y
    Rev Med Interne; 1986 Nov; Spec No():29-34. PubMed ID: 3809777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statewide test of a new postmarketing drug surveillance system.
    Fisher S; Bryant SG; Solovitz BL; Kluge RM
    Tex Med; 1987 Aug; 83(8):59-62. PubMed ID: 3660262
    [No Abstract]   [Full Text] [Related]  

  • 4. Critical reflection on the collection and evaluation of adverse drug reaction data.
    Venulet J
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S48-53. PubMed ID: 3842691
    [No Abstract]   [Full Text] [Related]  

  • 5. [Problems of the number of cases in drug surveillance].
    Auriche M
    Rev Med Interne; 1986 Nov; Spec No():45-51. PubMed ID: 3809780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The desire to regulate: the wish to discover.
    Lasagna L
    Drugs Exp Clin Res; 1987; 13(11):659-64. PubMed ID: 3443041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-marketing surveillance of new drugs.
    Buckley EG
    J R Coll Gen Pract; 1987 Aug; 37(301):337-8. PubMed ID: 3448222
    [No Abstract]   [Full Text] [Related]  

  • 8. Biological indicator test packs: a survey of user practices.
    Smith DE
    J Healthc Mater Manage; 1988; 6(4):38, 40-2. PubMed ID: 10287653
    [No Abstract]   [Full Text] [Related]  

  • 9. Adverse drug reaction monitoring: doing it the French way.
    Moore N; Biour M; Paux G; Loupi E; Begaud B; Boismare F; Royer RJ
    Lancet; 1985 Nov; 2(8463):1056-8. PubMed ID: 2865527
    [No Abstract]   [Full Text] [Related]  

  • 10. Monitoring of drugs after marketing.
    J R Coll Gen Pract; 1983 Jul; 33(252):438-41. PubMed ID: 6887114
    [No Abstract]   [Full Text] [Related]  

  • 11. EDPS of clinical case record and scientific document in the industry post-marketing surveillance of drugs.
    Kitaguchi T; Nojiri T; Suzuki S; Fukita T; Kawana T
    Methods Inf Med; 1983 Jul; 22(3):135-48. PubMed ID: 6633266
    [No Abstract]   [Full Text] [Related]  

  • 12. [A network of regional correspondents for studying undesirable effects].
    Haramburu F; Péré JC; Begaud B; Albin H
    Therapie; 1985; 40(5):321-4. PubMed ID: 4095688
    [No Abstract]   [Full Text] [Related]  

  • 13. Discovery of adverse drug reactions. A comparison of selected phase IV studies with spontaneous reporting methods.
    Rossi AC; Knapp DE; Anello C; O'Neill RT; Graham CF; Mendelis PS; Stanley GR
    JAMA; 1983 Apr 22-29; 249(16):2226-28. PubMed ID: 6834622
    [No Abstract]   [Full Text] [Related]  

  • 14. [Notification of possible adverse reactions to drugs in medical publications].
    Laporte JR; Capellà D
    Med Clin (Barc); 1984 Oct; 83(11):474. PubMed ID: 6503426
    [No Abstract]   [Full Text] [Related]  

  • 15. A potential use of the National Death Index for postmarketing drug surveillance.
    Edlavitch SA; Feinleib M; Anello C
    JAMA; 1985 Mar; 253(9):1292-5. PubMed ID: 3968855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bayesian approach to the imputability of undesirable phenomena to drugs].
    Auriche M
    Therapie; 1985; 40(5):301-6. PubMed ID: 4095686
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of record linkage in post-marketing drug surveillance.
    Crombie IK
    Br J Clin Pharmacol; 1986; 22 Suppl 1(Suppl 1):77S-82S. PubMed ID: 3567036
    [No Abstract]   [Full Text] [Related]  

  • 18. Round table: Post-marketing evaluation of fertility-regulating drugs as viewed by the pharmaceutical industry.
    Hum Reprod; 1987 Apr; 2(3):241-63. PubMed ID: 3597744
    [No Abstract]   [Full Text] [Related]  

  • 19. Adverse drug reaction reporting.
    Bosco LA
    Am J Gastroenterol; 1987 Apr; 82(4):356-7. PubMed ID: 3565343
    [No Abstract]   [Full Text] [Related]  

  • 20. [Critical study of methods of postmarketing drug surveillance].
    Gut JP; Auriche M; Spriet-Pourra C; Juillet Y
    Therapie; 1985; 40(5):313-9. PubMed ID: 3913048
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.